Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
1
users have commented on this narrative
39
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Ballard Power Systems
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Advancing Battery Technologies And Policy Gaps Will Erode Hydrogen Value
Key Takeaways Accelerating advances in battery technology and weak hydrogen infrastructure hinder Ballard's market attractiveness and limit scalable, recurring revenue growth. High operating costs, customer concentration, and increased competition threaten reliable profitability and expose the company to unpredictable financial performance.
View narrative
CA$1.00
FV
154.3% overvalued
intrinsic discount
16.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ChargePoint Holdings
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Regulatory Uncertainty Will Slow EV Charging Buildout Despite Eaton Support
Key Takeaways Regulatory uncertainty, weak demand, and macro volatility could limit revenue growth, strain utilization, and prolong unprofitability across ChargePoint's charging network operations. Heightened technological disruption and aggressive competition risk eroding ChargePoint's pricing power, accelerating obsolescence, and leading to further customer attrition and margin pressure.
View narrative
US$10.00
FV
17.9% overvalued
intrinsic discount
15.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Diversified Healthcare Trust
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Elevated Debt And Regulatory Pressure Will Weaken Senior Housing
Key Takeaways Heavy debt burden, rising interest expenses, and limited capital access threaten profitability, reinvestment capacity, and overall financial stability. Shifts in healthcare delivery and persistent tenant weakness undermine occupancy and revenue growth across core facility assets.
View narrative
US$3.00
FV
16.0% overvalued
intrinsic discount
2.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Evolv Technologies Holdings
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
AI Security Screening Will Face Overwhelming Regulatory And Pricing Headwinds
Key Takeaways Growing regulatory and privacy concerns, alongside commoditization and global competition, threaten Evolv's market adoption and pricing power. Reliance on a narrow product suite and ongoing operating losses risk shareholder dilution and declining recurring revenue visibility due to evolving buyer preferences.
View narrative
US$5.50
FV
34.0% overvalued
intrinsic discount
18.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Senseonics Holdings
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Dependence On One Sensor Will Intensify Risks Yet Improve Outlook
Key Takeaways Heavy reliance on a single implantable sensor platform exposes the company to risks from evolving technology and potential disruption by non-invasive alternatives. Regulatory pressures and high operating expenses may constrain margin expansion and delay the achievement of sustained profitability and positive cash flow.
View narrative
US$1.00
FV
51.9% undervalued
intrinsic discount
44.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Fulgent Genetics
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Regulatory Costs And Fierce Competition Will Choke Genomic Testing
Key Takeaways Heightened regulatory, privacy, and payer pressures threaten revenue growth, margin stability, and market size, potentially limiting the company's profitability and future expansion. Heavy spending on development and expansion efforts may not yield proportional returns due to fierce competition, rapid technological change, and ongoing industry commoditization.
View narrative
US$21.00
FV
3.5% overvalued
intrinsic discount
10.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Ouster
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Lidar Commoditization And Regulatory Hurdles Will Damage Prospects
Key Takeaways Competitive pressures and technological shifts threaten profitability and market share, while slower-than-expected adoption in key industries may hinder growth. Heavy dependence on major contracts and ongoing supply chain disruptions expose the company to heightened revenue and cost volatility.
View narrative
US$11.00
FV
218.6% overvalued
intrinsic discount
37.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Ranpak Holdings
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Tariff Hikes Will Hinder Packaging Operations But Automation Will Emerge
Key Takeaways Demand for recyclable packaging is rising, but advanced sustainable alternatives and large buyers threaten Ranpak's growth and pricing power. Automation and innovation investments may drive diversification, yet reliance on major customers and fixed costs create revenue and earnings volatility risks.
View narrative
US$5.00
FV
14.6% undervalued
intrinsic discount
8.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
DNA
Ginkgo Bioworks Holdings
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Intensifying Competition And Regulatory Burdens Will Hurt Synthetic Biology Revenue
Key Takeaways Reliance on project-based contracts and biosecurity funding creates revenue instability, while persistent negative cash flow limits the ability to scale and invest in growth. Intensifying competition, regulatory scrutiny, and public mistrust threaten market share and revenue realization as synthetic biology becomes more widely adopted.
View narrative
US$6.00
FV
115.0% overvalued
intrinsic discount
-7.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies